Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics

Table 3 Distribution of biochemistry, clinical and lifestyle characteristics in relation to serum triglycerides in the CONOR survey

	Non-fasting trigycerides (mmol/L)
	< 2.0		2.0-4.9		5.0-9.9		≥ 10		Total
	n	%	n	%	n	%	n	%	n	%
Non-fasting serum glucose (mmol/L)
< 7.0	103,889	94.5	35,527	88.0	2134	80.2	119	73.5	141,669	92.5
7.0-8.9	4432	4.0	3065	7.6	262	9.8	16	9.9	7775	5.1
9.0-10.9	855	0.8	759	1.9	95	3.6	2	1.2	1711	1.1
≥ 11.0	734	0.7	1006	2.5	170	6.4	25	15.4	1935	1.3
Total	109,910	100.0	40,357	100.0	2661	100.0	162	100.0	153,090	100.0
Systolic blood pressure (mmHg)
< 160	112,395	89.8	36,850	83.3	2376	81.5	149	86.1	151,770	88.0
≥ 160	12,715	10.2	7383	16.7	538	18.5	24	13.9	20,660	12.0
Total	125,110	100.0	44,233	100.0	2914	100.0	173	100.0	172,430	100.0
Body mass index (kg/m²)
< 20	6120	4.9	350	0.8	5	0.2	0	0.0	6475	3.8
20.0-24.9	58,443	46.8	9791	22.2	339	11.7	16	9.2	68,589	39.9
25.0-29.9	46,690	37.4	22,380	50.8	1464	50.5	85	49.1	70,619	41.1
≥ 30.0	13,501	10.8	11,506	26.1	1092	37.7	72	41.6	26,171	15.2
Total	124,754	100.0	44,027	100.0	2900	100.0	173	100.0	171,854	100.0
Have had myocardial infarction
Yes	3371	2.7	2193	5.0	146	5.1	10	5.8	5720	3.4
No	120,420	97.3	41,489	95.0	2718	94.9	163	94.2	164,790	96.6
Total	123,791	100.0	43,682	100.0	2864	100.0	173	100.0	170,510	100.0
Hard physical activity during one week
No	38,733	36.5	15,432	43.0	1089	46.0	58	38.4	55,312	38.3
< 1 h	26,506	25.0	9176	25.6	597	25.2	50	33.1	36,329	25.1
1 - 2 h	26,371	24.8	7328	20.4	449	19.0	34	22.5	34,182	23.6
≥ 3 h	14,575	13.7	3917	10.9	233	9.8	9	6.0	18,734	13.0
Total	106,185	100.0	35,853	100.0	2368	100.0	151	100.0	144,557	100.0
Daily smoking
No	87,015	70.1	30,394	69.4	1862	64.7	89	51.4	119,360	69.8
Yes	37,129	29.9	13,380	30.6	1016	35.3	84	48.6	51,609	30.2
Total	124,144	100.0	43,774	100.0	2878	100.0	173	100.0	170,969	100.0

ISSN: 1476-511X